The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or …

The global response to Coronavirus Disease 2019 (COVID-19) is now facing new
challenges such as vaccine inequity and the emergence of SARS-CoV-2 variants of concern …

Since its discovery in 2019, multiple variants of severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) have been identified. This study investigates virus spread and …

Vaccine-associated enhanced disease (VAED) is a difficult phenomenon to define and can
be confused with vaccine failure. Using studies on respiratory syncytial virus (RSV) …

Neutralizing antibodies (NAbs) are central players in the humoral immunity that defends the
body from SARS-CoV-2 infection by blocking viral entry into host cells and neutralizing their …

The fight against infectious diseases calls for the development of safe and effective vaccines
that generate long-lasting protective immunity. In a few situations, vaccine-mediated immune …

The tuberculosis vaccine, Bacille Calmette-Guerin (BCG), also affords protection against
non-tuberculous diseases attributable to heterologous immune mechanisms such as trained …

Chest X-ray (CXR), computed tomography (CT), and positron emission tomography–
computed tomography (PET-CT) are noninvasive imaging techniques widely used in human …

Antibiotic resistance represents a serious global health concern and has stimulated the
development of antimicrobial nanomaterials to combat resistant bacteria. Protein-based …

The novel coronavirus SARS-CoV-2 emerged in late 2019, rapidly reached pandemic
status, and has maintained global ubiquity through the emergence of variants of concern …